These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32836592)

  • 1. Preventing rather than punishing: An early warning model of malfeasance in public procurement.
    Gallego J; Rivero G; Martínez J
    Int J Forecast; 2021; 37(1):360-377. PubMed ID: 32836592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Contract-level Public Procurement Dataset.
    Fazekas M; Tóth B; Abdou A; Al-Shaibani A
    Data Brief; 2024 Jun; 54():110412. PubMed ID: 38698797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 5. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 6. [COUNTERACTION TO CORRUPTION DURING PUBLIC PROCUREMENT OF MEDICINAL PRODUCTS].
    Lohvynenko B; Podoliaka A; Domin Y; Kolesnikova I; Salaieva K
    Georgian Med News; 2022 Feb; (323):175-179. PubMed ID: 35271492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CENTRALIZATION AND CORRUPTION IN HEALTH PROCUREMENT OF THE SOUTHERN EUROPEAN UNION COUNTRIES.
    Geropoulos N; Voultsos P; Geropoulos M; Tsolaki F; Tagarakis G
    Georgian Med News; 2024 Mar; (348):10-21. PubMed ID: 38807383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [STATE PROCUREMENTS: STUDYING THE IMPLEMENTATION OF NATIONAL POLICIES IN TERMS OF PANDEMIC COVID-19].
    Ustymenko V; Soshnykov A; Tokarska A; Makarenko O; Nesterenko K
    Georgian Med News; 2021 Mar; (312):157-163. PubMed ID: 33964845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development aid contracts database: World Bank, Inter-American Development Bank, and EuropeAid.
    Fazekas M; Abdou A; Kazmina Y; Regős N
    Data Brief; 2022 Jun; 42():108121. PubMed ID: 35463053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corruption red flags in public procurement: new evidence from Italian calls for tenders.
    Decarolis F; Giorgiantonio C
    EPJ Data Sci; 2022; 11(1):16. PubMed ID: 35371906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of environmental corruption in healthcare infrastructures: An empirical assessment for Italy using DEA with truncated regression approach.
    Cavalieri M; Guccio C; Rizzo I
    Health Policy; 2017 May; 121(5):515-524. PubMed ID: 28318606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Underlying Factors of Corruption in the Public Construction Sector: Evidence from China.
    Shan M; Le Y; Yiu KTW; Chan APC; Hu Y
    Sci Eng Ethics; 2017 Dec; 23(6):1643-1666. PubMed ID: 28039612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing BIM implementation in Spanish public procurement: A framework approach.
    Pérez-García A; Martín-Dorta N; Aranda JÁ
    Heliyon; 2024 May; 10(9):e30650. PubMed ID: 38756612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOPPA: an open database of French public procurement award notices from 2010-2020.
    Potin L; Labatut V; Morand PH; Largeron C
    Sci Data; 2023 May; 10(1):303. PubMed ID: 37208354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-related requirements in Swedish public sector procurement of health and welfare technologies - a systematic review.
    Richardson MX; Landerdahl Stridsberg S; Wamala Andersson S
    BMC Health Serv Res; 2022 Mar; 22(1):357. PubMed ID: 35300663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untangling the corruption maze: exploring the complexity of corruption in the health sector.
    Sommersguter-Reichmann M; Reichmann G
    Health Econ Rev; 2024 Jul; 14(1):50. PubMed ID: 38995456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria.
    Onwujekwe O; Orjiakor C; Ogbozor P; Agu I; Agwu P; Wright T; Balabanova D; Kohler J
    J Pharm Policy Pract; 2023 Nov; 16(1):141. PubMed ID: 37957711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?
    Vogler S; Salcher-Konrad M; Habimana K
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(8):867-878. PubMed ID: 37450611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.